Analystreport

AnaptysBio Inc (NASDAQ: ANAB) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations